Sign in
A consolidated, AI-driven view of financial strength across every rated company in this industry — ranked by Economic Capital Ratio, with the causal reasoning behind each score.
Protokinetix Inc climbed 372 positions from 451 to 79 due to its excellent Intangible Assets. Ayala Pharmaceuticals Inc lost 175 positions from 109 to 284 due to its bad Stockholders Equity. Diamedica Therapeutics Inc entered the 2024 ranking at rank 15, making it the best newcomer.
All 309 rated companies in US Pharma, 2024.
| Rank | Company | Seal | Economic Capital Ratio | Trend |
|---|
How the RealRate model weighs this industry — feature impact, importance, and fit.
The Feature Distribution shows the main industry variables and the distribution of their impact on financial strength. The more important a variable, the broader the distribution. As the effects are calculated relative to the industry average, half of the companies have a positive effect (green) and half have a negative effect (red).
The Feature Importance Graph highlights the most important industry features for the industry. These variables have the greatest impact on financial health, shown as the last variable at the bottom of the causal graph.
The Regression Plot compares the forecasted company valuation with the observed stock market values. A positive correlation suggests that the model effectively explains market prices.
